Atlas Trials

B-amyloid as a Marker for GBM Bioimaging

Clinical trial NCT05820191 · UNKNOWN

Trial details

NCT number
NCT05820191
Sponsor
Universidad Central del Caribe
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2024-07-01
Primary completion
2026-07-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.